Skip to main content
Clinical Trials/CTRI/2023/03/050222
CTRI/2023/03/050222
Completed
未知

To evaluate the in-vivo efficacy and safety of a skin care regime in terms of anti-aging effects i.e., reduction in fine lines and wrinkles, reduction in density of dark spots (age spots), improvement in skin moisturization, improvement in skin brightening and improvement in skin firmness on healthy female subjects.

BRIGHT LIFECARE PVT. LTD.0 sites33 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
BRIGHT LIFECARE PVT. LTD.
Enrollment
33
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 28, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
BRIGHT LIFECARE PVT. LTD.

Eligibility Criteria

Inclusion Criteria

  • 1\.Indian female subjects.
  • 2\.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
  • 3\.Between 35 and 55 years of age.
  • 4\.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)

Exclusion Criteria

  • 1\.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • 2\.Having refused to give her/his assent by signing the consent form
  • 3\.Taking part in another study liable to interfere with this study
  • 4\.Being insulin\-dependent diabetic or non\-insulin\-dependent diabetic with a recent therapy (less than 6 months)
  • 5\.Being asthmatic.
  • 6\. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
  • 7\.Following a chronic medicinal treatment comprising any of the following products: aspirin\-based products, anti\-inflammatories, anti\-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • 8\.Having cutaneous hypersensitivity.
  • 9\.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
  • 10\.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials